Loading organizations...
Loading organizations...
Biotechnology company advancing neonatal cardiac progenitor cell therapies.
NeoProgen has raised $1.5M across 1 funding round.
NeoProgen has raised $1.5M in total across 1 funding round.
NeoProgen has raised $1.5M in total across 1 funding round.
NeoProgen's investors include Claire Broido Johnson, TEDCO, UM Ventures, University of Maryland.
NeoProgen has raised $1.5M across 1 funding round. Most recently, it raised $1.5M Seed in October 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 16, 2019 | $1.5M Seed | Claire Broido Johnson | TEDCO, UM Ventures, University of Maryland |